Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa

被引:0
作者
Mercedes Delgado-Valverde
Inés Portillo-Calderón
Manuel Alcalde-Rico
M. Carmen Conejo
Carmen Hidalgo
Carlos del Toro Esperón
Álvaro Pascual
机构
[1] Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla,UGC Enfermedades Infecciosas y Microbiología Clínica, Instituto de Biomedicina de Sevilla (IBIS)
[2] Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC),Instituto de Biomedicina de Sevilla
[3] Hospital Universitario Virgen Macarena,Departamento de Microbiología
[4] CSIC,undefined
[5] Universidad de Sevilla,undefined
[6] Universidad de Sevilla,undefined
来源
European Journal of Clinical Microbiology & Infectious Diseases | 2024年 / 43卷
关键词
Imipenem/relebactam; Carbapenem-resistant;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:445 / 457
页数:12
相关论文
共 107 条
  • [1] Barrasa-Villar JI(2017)Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms Clin Infect Dis 15 644-652
  • [2] Aibar-Remón C(2018)Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis Lancet Infect Dis 18 318-327
  • [3] Prieto-Andrés P(2020)New β-lactam-β-lactamase inhibitor combinations Clin Microbiol Rev 34 1-61
  • [4] Mareca-Doñate R(2017)Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance FEMS Microbiol Rev 41 252-275
  • [5] Moliner-Lahoz J(2015)Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance Antimicrob Agents Chemother 59 5873-5884
  • [6] Tacconelli E(2009)Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms Clin Microbiol Rev 22 582-610
  • [7] Carrara E(2019)Antibiotic resistance in Pseudomonas aeruginosa - mechanisms, epidemiology and evolution Drug Resist Updat 44 100640-976
  • [8] Savoldi A(2010)Updated functional classification of beta-lactamases Antimicrob Agents Chemother 54 969-2290
  • [9] Harbarth S(2013)Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa J Antimicrob Chemother 68 2286-4308
  • [10] Mendelson M(2020)A clinical review and critical evaluation of imipenem-relebactam: evidence to date Infect Drug Resist 13 4297-1808